FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012134028> ?p ?o ?g. }

• W2012134028 endingPage "381" @default.
• W2012134028 startingPage "364" @default.
• W2012134028 abstract "Depression is one of the largest causes of disease burden globally but can routinely go undetected in primary care. Screening for depression is an effective way to increase early recognition, and there is an opportunity to utilize pharmacists' skills and accessibility to do this. The overall aim of this study was to determine the feasibility of Australian community pharmacists performing screening and risk assessment services for depression. The specific objectives were to: (1) develop a depression screening training program to aid pharmacists in the screening and risk assessment of depression in community pharmacy, (2) assess the feasibility of pharmacists using a screening tool for depression, (3) assess pharmacists' perspectives on the ease of use of different screening tools in the community pharmacy setting and (4) investigate the barriers and facilitators to pharmacists performing screening and risk assessment services for depression in community pharmacy. Twenty pharmacists from 12 community pharmacies were recruited. A training program on depression was developed and delivered to the pharmacists, followed by an eight week data collection period during which pharmacists conducted patient screenings for depression. Semi-structured interviews were conducted at the end of the data collection period to gather pharmacists' reflections on the intervention and to explore the barriers and facilitators to depression screening and risk assessment. Forty-one screening and risk assessments were conducted from 75 consumers who were approached. The majority of consumers screened were female, less than 40 years old and previously known to the pharmacy. More than 70% of consumers were referred on to a GP or psychologist for assessment. Barriers to implementation of the service included time, stigma and a lack of awareness of the pharmacists' role. Facilitators to the service included the accessibility of the pharmacist, having a private consultation area in the pharmacy, awareness campaigns and mental health resources on display. Pharmacists are capable of performing screening and risk assessment services for depression and making referrals to appropriate health care professionals when required. Pharmacy based depression screening programs have the potential to increase the early detection of depression which may lead to early intervention, and potentially contribute to easing the enormous disease burden associated with depression." @default.
• W2012134028 created "2016-06-24" @default.
• W2012134028 creator A5037784949 @default.
• W2012134028 creator A5053574319 @default.
• W2012134028 creator A5077772350 @default.
• W2012134028 date "2015-05-01" @default.
• W2012134028 modified "2023-10-17" @default.
• W2012134028 title "A feasibility study of community pharmacists performing depression screening services" @default.
• W2012134028 cites W1552145872 @default.
• W2012134028 cites W1866754648 @default.
• W2012134028 cites W1968281625 @default.
• W2012134028 cites W1969197088 @default.
• W2012134028 cites W1982009351 @default.
• W2012134028 cites W1984615306 @default.
• W2012134028 cites W1985238601 @default.
• W2012134028 cites W1985334460 @default.
• W2012134028 cites W1985394871 @default.
• W2012134028 cites W1994323823 @default.
• W2012134028 cites W1995490323 @default.
• W2012134028 cites W1998223959 @default.
• W2012134028 cites W2020164855 @default.
• W2012134028 cites W2024751320 @default.
• W2012134028 cites W2032172566 @default.
• W2012134028 cites W2034544386 @default.
• W2012134028 cites W2052486231 @default.
• W2012134028 cites W2056863568 @default.
• W2012134028 cites W2088728249 @default.
• W2012134028 cites W2090310653 @default.
• W2012134028 cites W2091333573 @default.
• W2012134028 cites W2094026162 @default.
• W2012134028 cites W2096000431 @default.
• W2012134028 cites W2106744754 @default.
• W2012134028 cites W2114053294 @default.
• W2012134028 cites W2122884679 @default.
• W2012134028 cites W2127184046 @default.
• W2012134028 cites W2132322340 @default.
• W2012134028 cites W2141926386 @default.
• W2012134028 cites W2151537332 @default.
• W2012134028 cites W2154690800 @default.
• W2012134028 cites W2156104108 @default.
• W2012134028 cites W2165526480 @default.
• W2012134028 cites W2166073928 @default.
• W2012134028 cites W2168628364 @default.
• W2012134028 cites W4238089245 @default.
• W2012134028 cites W4256651730 @default.
• W2012134028 doi "https://doi.org/10.1016/j.sapharm.2014.08.013" @default.
• W2012134028 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25438728" @default.
• W2012134028 hasPublicationYear "2015" @default.
• W2012134028 type Work @default.
• W2012134028 sameAs 2012134028 @default.
• W2012134028 citedByCount "47" @default.
• W2012134028 countsByYear W20121340282014 @default.
• W2012134028 countsByYear W20121340282015 @default.
• W2012134028 countsByYear W20121340282016 @default.
• W2012134028 countsByYear W20121340282017 @default.
• W2012134028 countsByYear W20121340282018 @default.
• W2012134028 countsByYear W20121340282019 @default.
• W2012134028 countsByYear W20121340282020 @default.
• W2012134028 countsByYear W20121340282021 @default.
• W2012134028 countsByYear W20121340282022 @default.
• W2012134028 countsByYear W20121340282023 @default.
• W2012134028 crossrefType "journal-article" @default.
• W2012134028 hasAuthorship W2012134028A5037784949 @default.
• W2012134028 hasAuthorship W2012134028A5053574319 @default.
• W2012134028 hasAuthorship W2012134028A5077772350 @default.
• W2012134028 hasConcept C10446079 @default.
• W2012134028 hasConcept C104863432 @default.
• W2012134028 hasConcept C139719470 @default.
• W2012134028 hasConcept C159110408 @default.
• W2012134028 hasConcept C162324750 @default.
• W2012134028 hasConcept C2776867660 @default.
• W2012134028 hasConcept C2780665704 @default.
• W2012134028 hasConcept C2994493120 @default.
• W2012134028 hasConcept C512399662 @default.
• W2012134028 hasConcept C71924100 @default.
• W2012134028 hasConceptScore W2012134028C10446079 @default.
• W2012134028 hasConceptScore W2012134028C104863432 @default.
• W2012134028 hasConceptScore W2012134028C139719470 @default.
• W2012134028 hasConceptScore W2012134028C159110408 @default.
• W2012134028 hasConceptScore W2012134028C162324750 @default.
• W2012134028 hasConceptScore W2012134028C2776867660 @default.
• W2012134028 hasConceptScore W2012134028C2780665704 @default.
• W2012134028 hasConceptScore W2012134028C2994493120 @default.
• W2012134028 hasConceptScore W2012134028C512399662 @default.
• W2012134028 hasConceptScore W2012134028C71924100 @default.
• W2012134028 hasIssue "3" @default.
• W2012134028 hasLocation W20121340281 @default.
• W2012134028 hasLocation W20121340282 @default.
• W2012134028 hasOpenAccess W2012134028 @default.
• W2012134028 hasPrimaryLocation W20121340281 @default.
• W2012134028 hasRelatedWork W1651523177 @default.
• W2012134028 hasRelatedWork W1939101705 @default.
• W2012134028 hasRelatedWork W2016257634 @default.
• W2012134028 hasRelatedWork W2059072061 @default.
• W2012134028 hasRelatedWork W2093850161 @default.
• W2012134028 hasRelatedWork W2357033819 @default.
• W2012134028 hasRelatedWork W2556285765 @default.
• W2012134028 hasRelatedWork W2981671997 @default.

• next